T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Oshkosh
OSK
$9.61B
| $12.3M | ﹤0.01% |
98,026
+50,876
| +108% | +$6.54M |
|
1177
Portland General Electric
POR
$5.74B
| $12.3M | ﹤0.01% |
255,825
+27,722
| +12% | +$1.31M |
|
1178
APA Corp
APA
$14B
| $12.2M | ﹤0.01% |
498,477
-12,578
| -2% | -$304K |
|
1179
Coastal Financial
CCB
$754M
| $12.1M | ﹤0.01% |
105,734
+293
| +0.3% | +$32K |
|
1180
UGI
UGI
$7.53B
| $12.1M | ﹤0.01% |
322,763
+22,819
| +8% | +$808K |
|
1181
ITT
ITT
$19.4B
| $12.1M | ﹤0.01% |
69,591
+6,088
| +10% | +$1.09M |
|
1182
Fidelity National Financial
FNF
$12.8B
| $12M | ﹤0.01% |
220,617
+9,040
| +4% | +$515K |
|
1183
MasTec
MTZ
$22.6B
| $11.9M | ﹤0.01% |
54,783
+3,635
| +7% | +$763K |
|
1184
Stoke Therapeutics
STOK
$2.02B
| $11.8M | ﹤0.01% |
372,334
+321,071
| +626% | +$9.65M |
|
1185
W.P. Carey
WPC
$16.1B
| $11.8M | ﹤0.01% |
183,298
-468,518
| -72% | -$31.2M |
|
1186
Carlisle Companies
CSL
$15.2B
| $11.6M | ﹤0.01% |
36,403
+279
| +0.8% | +$90.4K |
|
1187
Alamo Group
ALG
$2.01B
| $11.6M | ﹤0.01% |
69,329
+41,491
| +149% | +$7.23M |
|
1188
Match Group
MTCH
$8.4B
| $11.6M | ﹤0.01% |
359,521
-4,729
| -1% | -$155K |
|
1189
Magnite
MGNI
$3.49B
| $11.5M | ﹤0.01% |
711,495
-1,836,010
| -72% | -$30.5M |
|
1190
Sensient Technologies
SXT
$5.53B
| $11.5M | ﹤0.01% |
122,751
+8,079
| +7% | +$762K |
|
1191
Personalis
PSNL
$1.54B
| $11.5M | ﹤0.01% |
1,448,585
+1,347,439
| +1,332% | +$11.8M |
|
1192
Paycom
PAYC
$9.52B
| $11.5M | ﹤0.01% |
72,095
+1,457
| +2% | +$258K |
|
1193
Henry Schein
HSIC
$10.1B
| $11.5M | ﹤0.01% |
151,610
+883
| +0.6% | +$62.1K |
|
1194
Watsco Inc
WSO
$12.8B
| $11.4M | ﹤0.01% |
33,791
+1,887
| +6% | +$674K |
|
1195
Generac Holdings
GNRC
$13.1B
| $11.4M | ﹤0.01% |
83,363
-705
| -0.8% | -$114K |
|
1196
Riot Platforms
RIOT
$7.21B
| $11.3M | ﹤0.01% |
893,416
+104,633
| +13% | +$1.79M |
|
1197
Applied Digital
APLD
$8.81B
| $11.3M | ﹤0.01% |
461,126
-3,642,846
| -89% | -$105M |
|
1198
Graco
GGG
$13.4B
| $11.3M | ﹤0.01% |
137,669
+4,166
| +3% | +$343K |
|
1199
Molson Coors Class B
TAP
$7.75B
| $11.2M | ﹤0.01% |
240,946
-182,409
| -43% | -$8.41M |
|
1200
Eos Energy Enterprises
EOSE
$1.51B
| $11.2M | ﹤0.01% |
979,739
-1,267,735
| -56% | -$18.2M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.